SCHEMBL29944874

SCHEMBL29944874

CCOC(=O)c1cc(Cl)cc(C=O)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.50
CA1 P00915 3/20 0.50
CA2 P00918 3/20 0.50
CA7 P43166 3/20 0.50
CA9 Q16790 3/20 0.50
CA14 Q9ULX7 3/20 0.50
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
ALOX15 P16050 1/20 0.43
ESR1 P03372 1/20 0.42
ESR2 Q92731 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
BCL2L1 Q07817 1/20 0.41
CYP3A4 P08684 2/20 0.41
LMNA P02545 1/20 0.41
CYP1A2 P05177 1/20 0.41
MAOA P21397 1/20 0.41
TRPV1 Q8NER1 1/20 0.41
KDM4E B2RXH2 1/20 0.40
NPC1 O15118 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27030501 1.00 CA12 (0.50) CA12CA1CA2CA7CA9
SCHEMBL475420 0.88 CA12 (0.58) CA12CA1CA2CA7CA9
SCHEMBL7589274 0.84 CA12 (0.62) CA12CA1CA2CA7CA9
SCHEMBL2662880 0.84 CA12 (0.62) CA12CA1CA2CA7CA9
SCHEMBL14209383 0.82 CA12 (0.51) CA12CA1CA2CA7CA9
SCHEMBL4755061 0.82 PTGS2 (0.53) CA12CA1CA2CA7CA9
SCHEMBL4755064 0.82 PTGS2 (0.53) CA12CA1CA2CA7CA9
SCHEMBL3365862 0.81 ALDH1A1 (0.55) CA12CA1CA2CA7CA9
SCHEMBL30546183 0.81 ALDH1A1 (0.55) CA12CA1CA2CA7CA9
SCHEMBL15615318 0.80 CA12 (0.56) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4308554-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING TYPE 2 DIABETES AND DEMENTIA The Board of Trustees of the University of Illinois (US) 2024-01-24 EP disclosed
WO-2022197658-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING TYPE 2 DIABETES AND DEMENTIA THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2022-09-22 WO disclosed